Scientists have discovered 'berkelocene,' the first organometallic molecule to be characterized containing the heavy element berkelium. The breakthrough disrupts long-held theories about the chemistry ...
A 4D Molecular Therapeutics, Inc. phase 2 PRISM study indicated that there was an 89% reduction in annualized injections when Wet-AMD patients were given a high dose of 4D-150; Phase 3 trial ...
BUFFALO, N.Y. — Scientists from the University at Buffalo and the Department of Energy’s Lawrence Berkeley National Laboratory have discovered “berkelocene,” the first organometallic molecule to be ...